Biotech · Private company
Senseye, Inc.
Track this companyFree. Adds Senseye, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Clinician Administered PTSD Scale for DSM-5, Revised VersionPhase 3 · PTSD - Post Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
- Senseye Diagnostic Tool (DT)Phase 3 · PTSD - Post Traumatic Stress DisorderClinicalTrials.gov · fetched Nov 12, 2026
- CAPS-5 AssessmentPTSDClinicalTrials.gov · fetched Nov 12, 2026
- CAPS-5-RPTSDClinicalTrials.gov · fetched Nov 12, 2026
- Senseye DTPTSDClinicalTrials.gov · fetched Nov 12, 2026
- Senseye OBCIPTSDClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic ToolPHASE3 · RECRUITING · started Feb 23, 2026ClinicalTrials.gov NCT07280065 · fetched Nov 12, 2026
- Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSDCOMPLETED · started Mar 1, 2023ClinicalTrials.gov NCT05717439 · fetched Nov 12, 2026
- Senseye's OBCI Diagnostic Tool for PTSDTERMINATED · started Apr 25, 2022ClinicalTrials.gov NCT05372523 · fetched Nov 12, 2026